Clinical Outcomes of Patients with Diabetes Mellitus and Acute ST-elevation Myocardial Infarction Following Fibrinolytic Therapy: A Nationwide Inpatient Sample (NIS) Database Analysis.
CONCLUSION: Diabetic patients receiving fibrinolytic therapy for STEMI might have higher odds of all-cause mortality and cardiogenic shock compared to non-diabetic patients.
PMID: 33567924 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
More News: Bleeding | Cardiogenic Shock | Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Attack